🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Vancouver
Clinical trial register · Canada

Clinical Trials in Vancouver, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6540 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:55 UTC
6540
Studies in scope
all four open statuses
3515
Recruiting now
open to new participants
887
Lead sponsors
across recruiting studies
Top sites
Vancouver 31 Kelowna 10 Surrey 6 Victoria 6 Prince George 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of British Columbia179 AstraZeneca54 Canadian Cancer Trials Group38 National Cancer Institute (NCI)36 British Columbia Cancer Agency31 Clear sponsor filter
Site location
Vancouver31 Kelowna10 Surrey6 Victoria6 Prince George5
All 12 locations
Target enrolment
to

Trials with a site in Vancouver

31 of 6540 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
High Dose Radiotherapy for Palliation (Hi-D)
NCT07291895Metastases, Palliative Radiotherapy
British Columbia Cancer Agency
Not applicable
21
Vancouver
2027-03-01
Not yet open
A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies
NCT07621146Neuroendocrine Tumors, NET, Pheochromocytoma/Paraganglioma, SSTR-expressing Tumors, Medullary Thyroid Carcinoma
British Columbia Cancer Agency
Observational
51
Vancouver
2026-09-15
Recruiting
Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life
NCT07255001Pancreatic Ductal Adenocarcinoma (PDAC), Hand Grip Strength
British Columbia Cancer Agency
Not applicable
50
Vancouver
2026-08-13
Recruiting
HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG
NCT07295171Multiple Cancers, Multiple Indications Cancer, Feasibility Studies
British Columbia Cancer Agency
Not applicable
27
Vancouver
2026-02-18
Recruiting
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
NCT06574620Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
British Columbia Cancer Agency
Not applicable
200
Vancouver
2025-11-28
Not yet open
Radiotherapy 12Gy in 6 Fractions For Orbital Lymphoma
NCT07210749Orbital Lymphoma
British Columbia Cancer Agency
Not applicable
36
Vancouver
2025-11-01
Not yet open
SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors
NCT06937281Breast Cancer, Metastases
British Columbia Cancer Agency
Not applicable
40
Vancouver
2025-07-01
Not yet open
DOTATATE PET for Meningioma Radiation Planning
NCT06937268Meningioma
British Columbia Cancer Agency
Not applicable
36
Vancouver
2025-06
Recruiting
Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer
NCT06665178Breast Cancer
DrugSacituzumab Govitecan
British Columbia Cancer Agency
Phase 2
20
Vancouver
2025-03-31
Recruiting
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
NCT06208735B-Cell Leukemia, Non-Hodgkin's Lymphoma, B-cell Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma
British Columbia Cancer Agency
Phase 1
24
Calgary, Vancouver, Ottawa, Toronto
2025-01-02
Recruiting
STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
NCT05576831Vulvar Cancer
British Columbia Cancer Agency
Not applicable
249
Vancouver
2024-11-25
Recruiting
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
NCT05132244Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, Hyperglycemia
British Columbia Cancer Agency
Not applicable
50
Vancouver, Toronto
2024-04-16
Recruiting
Evidence Development in Cancer Treatment - Real World: PREDiCTrw
NCT06242912Cancer
British Columbia Cancer Agency
Not applicable
100
Vancouver
2024-01-22
By invitation
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
NCT05570994Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer
British Columbia Cancer Agency
Phase 1/2
50
Vancouver
2024-01-01
Recruiting
Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
NCT06628102Lung Cancer, Pulmonary Nodule
British Columbia Cancer Agency
Not applicable
3,600
Vancouver
2023-08-04
Recruiting
CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease
NCT05257967EGFR Activating Mutation, Leptomeningeal Metastasis, Non Small Cell Lung Cancer
British Columbia Cancer Agency
Not applicable
10
Vancouver
2022-07-18
Active, closed
RAPid SimPLE Targeted Radiation Treatment for Brain Metastases
NCT05050929Brain Metastases, Adult
British Columbia Cancer Agency
Phase 2
100
Abbotsford British Columbia, Kelowna, Prince George, Surrey, Vancouver, Victoria
2022-07-01
Recruiting
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
NCT04610372Oligometastatic Prostate Cancer
British Columbia Cancer Agency
Not applicable
168
Kelowna, Surrey, Vancouver, Victoria
2021-07-12
Recruiting
PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc
NCT04814095Cancer
British Columbia Cancer Agency
Not applicable
30
Vancouver
2021-06-30
Active, closed
PRecision Oncology Evidence Development in Cancer Treatment - Liquid
NCT05057234Cancer
British Columbia Cancer Agency
Not applicable
1,500
Vancouver
2021-06-18
Active, closed
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer
NCT04484701Prostatic Neoplasm, Prostatic Cancer
DrugIlluccix
British Columbia Cancer Agency
Observational
1,574
Vancouver
2021-02-01
Active, closed
PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA
NCT04015622Metastatic Castration-Resistant Prostate Cancer (mCRPC)
DrugsXtandi·Taxotere·Enzalutamide·Docetaxel
British Columbia Cancer Agency
Phase 2
100
Kelowna, Prince George, Surrey, Toronto, Vancouver, Victoria, London
2020-10-07
Recruiting
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
NCT04273061Breast Cancer, Lung Cancer, Gastrointestinal Cancer, Genitourinary Cancer
DrugsTecentriq·Atezolizumab
British Columbia Cancer Agency
Phase 2
50
Vancouver, Toronto
2020-06-17
Active, closed
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
NCT03862911Metastatic Tumors
British Columbia Cancer Agency
Not applicable
330
Calgary, Kelowna, Prince George, Surrey, Vancouver, Victoria, London, Saint Catharines
2019-11-01
Active, closed
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
NCT03917082Breast Cancer Female, Hormone Receptor Positive Tumor
DrugTamoxifen Citrate
British Columbia Cancer Agency
Phase 2
290
Vancouver
2019-09-23
Recruiting
Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease
NCT03836196Prostate Cancer
British Columbia Cancer Agency
Not applicable
105
Vancouver
2019-09-13
Active, closed
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
NCT03769103Lung Cancer Non-small Cell Stage IV, Brain Metastases
DrugOsimertinib
British Columbia Cancer Agency
Phase 2
40
Vancouver, Toronto
2019-03-19
Active, closed
DOTATOC PET/CT for Imaging NET Patients
NCT03583528Neuroendocrine Tumors, Insulinoma, Gastrinoma, Glucagonoma
British Columbia Cancer Agency
Observational
800
Vancouver
2018-07-11
Active, closed
PSMA PET/CT for Assessment of Recurrent Prostate Cancer
NCT02899312Prostatic Neoplasms, Prostate Cancer
British Columbia Cancer Agency
Observational
2,244
Vancouver
2017-03-16
Recruiting
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802Cancer, Pancreatic Cancer
British Columbia Cancer Agency
Observational
190
Calgary, Edmonton, Vancouver, Ottawa
2016-10-06
Recruiting
Personalized Oncogenomics (POG) Program of British Columbia
NCT02155621Metastatic Cancers, Advanced Cancers, Cancers That Cannot be Treated With Curative Intent
British Columbia Cancer Agency
Not applicable
5,000
Vancouver
2014-07
Rows per page Showing 1–31 of 31
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 September 2026. https://priyalifescience.com/clinical-trials-canada/city/vancouver

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,540 studies in total at the last sync on 26 Sep 2026, 19:55 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 31 of those studies with a site in Vancouver that also match the filters currently applied.

How many clinical trials are recruiting in Vancouver?

16 of the 31 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:55 UTC sync. A further 5 have not yet opened recruitment, 9 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Vancouver), 31 studies
PhaseStudiesRecruitingShare
Not applicable181258.1%
Phase 26219.4%
Observational5116.1%
Phase 1113.2%
Phase 1/2103.2%

Most active sponsors

Lead sponsors with the most studies (Vancouver)
Lead sponsorStudiesRecruiting
British Columbia Cancer Agency3116
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.